Published on medhub.novartis.com.ph (https://www.medhub.novartis.com.ph)

Home > Printer-friendly > Ranimizumab (Lucentis) Product Safety Information

Ranimizumab (Lucentis) Product Safety Information [1]

The following product safety information are essential to ensure the safe and effective use of Ranimizumab (Lucentis).

Ranimizumab (Lucentis) Product Safety Information - Diabetic Macular Edema (DME)

Download the PDF here >> [2]

 

Ranimizumab (Lucentis) Product Safety Information - Neovascular (Wet) Age-Related Macular Degeneration (wAMD)

Download the PDF here >> [3]

 

Ranimizumab (Lucentis) Product Safety Information - Retinal Vein Occlusion (RVO)

Download the PDF here>> [4]

 

Ranimizumab (Lucentis) Product Safety Information - Proliferative Diabetic Retinopathy (PDR)

Download the PDF here>> [5]

 

Ranimizumab (Lucentis) Product Safety Information - Choroidal Neovascularization (CNV)

Download the PDF here>> [6]

 

Do you find this content useful?: 
No votes yet
Source URL:https://www.medhub.novartis.com.ph/services/rmp-materials/ranimizumab-lucentis-product-safety-information

Links
[1] https://www.medhub.novartis.com.ph/services/rmp-materials/ranimizumab-lucentis-product-safety-information [2] https://www.medhub.novartis.com.ph/system/files/Ranimizumab%20%28Lucentis%29%20Product%20Safety%20Information%20-%20DME.pdf [3] https://www.medhub.novartis.com.ph/system/files/Ranimizumab%20%28Lucentis%29%20Product%20Safety%20Information%20-%20wAMD.pdf [4] https://www.medhub.novartis.com.ph/system/files/Ranimizumab%20%28Lucentis%29%20Product%20Safety%20Information%20-%20RVO.pdf [5] https://www.medhub.novartis.com.ph/system/files/Ranimizumab%20%28Lucentis%29%20Product%20Safety%20Information%20-%20PDR.pdf [6] https://www.medhub.novartis.com.ph/system/files/Ranimizumab%20%28Lucentis%29%20Product%20Safety%20Information%20-%20CNV.pdf